13 Papers
35 Citations
Bodnev Sa is an academic researcher from State Research Center of Virology and Biotechnology VECTOR. The author has contributed to research in topics: Monkeypox virus & Ebola virus. The author has an hindex of 7, co-authored 13 publications.
Chat about Author
Papers
Survival of aerosolized coronavirus in the ambient air.
TL;DR: The MERS-CoV virus demonstrated high robustness and strong capability to survive with about 63.5% of microorganisms remaining infectious 60min after aerosolisation but virus decay was much stronger for hot and dry air scenario with only 4.7% survival over 60min procedure.
163
A Kunjin Replicon Virus-like Particle Vaccine Provides Protection Against Ebola Virus Infection in Nonhuman Primates
Oleg V. Pyankov,Bodnev Sa,Olga G. Pyankova,Vladislav V. Solodkyi,Stepan A. Pyankov,Yin Xiang Setoh,Valentina A. Volchkova,Andreas Suhrbier,Viktor V. Volchkov,Alexander A. Agafonov,Alexander A. Khromykh +10 more
TL;DR: It is suggested that KUN VLPs encoding GP/D637L represent a viable EBOV vaccine candidate in nonhuman primates.
Molecular epidemiology of noroviruses associated with sporadic gastroenteritis in children in Novosibirsk, Russia, 2003-2012.
Elena Zhirakovskaia,Artem Tikunov,Bodnev Sa,Vera Klemesheva,Sergey V. Netesov,Nina V. Tikunova +5 more
TL;DR: NoV was detected throughout the year with a seasonal increase during winter months and their ratio changed every season, but it was different depending on NoV genotype.
39
Using the Ground Squirrel ( Marmota bobak ) as an Animal Model to Assess Monkeypox Drug Efficacy
Sergeev Aa,A. S. Kabanov,Bulychev Le,Oleg V. Pyankov,Bodnev Sa,Darya O. Galahova,A. S. Zamedyanskaya,K. A. Titova,Glotova Ti,O. S. Taranov,Omigov Vv,Larisa N. Shishkina,Alexander P. Agafonov,Sergeev An +13 more
TL;DR: The use of this animal species to assess the antiviral efficacy of some drugs demonstrated the agreement of the obtained results with those described in scientific literature, which opens up the prospects of using marmots as animal models for monkeypox to develop therapeutic and preventive anti‐smallpox drugs.
27
Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG.
Oleg V. Pyankov,Yin Xiang Setoh,Bodnev Sa,Judith H. Edmonds,Olga G. Pyankova,Stepan A. Pyankov,Gabor Pali,Shane Belford,Louis Lu,Mylinh La,George O. Lovrecz,Valentina A. Volchkova,Keith J. Chappell,Daniel Watterson,Glenn A. Marsh,Paul R. Young,Alexander A. Agafonov,Jillann F. Farmer,Victor E. Volchkov,Andreas Suhrbier,Alexander A. Khromykh +20 more
TL;DR: Production of purified equine IgG obtained from horses immunized with plasmid DNA followed by boosting with Kunjin replicon virus-like particles both encoding a modified Ebola glycoprotein may find utility as a post-exposure prophylactic for Ebola infection.